Elevai Labs (ELAB) Short Interest Ratio & Short Volume

Short interest is the volume of Elevai Labs shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 335,000 shares of ELAB short. Learn More on Elevai Labs' current short interest.

Elevai Labs saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 335,000 shares, an increase of 10.1% from the previous total of 304,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elevai Labs: Carisma Therapeutics, Inc. (3.27%), Lipocine Inc. (1.50%), Aprea Therapeutics, Inc. (0.94%), Leap Therapeutics, Inc. (11.24%), MIRA Pharmaceuticals, Inc. (5.28%), Cocrystal Pharma, Inc. (0.24%), GlycoMimetics, Inc. (3.15%), Marker Therapeutics, Inc. (3.03%), Athira Pharma, Inc. (2.69%), MEI Pharma, Inc. (0.09%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling ELAB is an investing strategy that aims to generate trading profit from Elevai Labs as its price is falling. ELAB shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Elevai Labs occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELAB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELAB, twice per month. The most recent reporting period available is January, 31 2025.